Tuberculosis continues to kill 1· 4 million people annually. During the past 5 years, an
alarming increase in the number of patients with multidrug-resistant tuberculosis and …

Tuberculosis (TB) continues to be a devastating infectious disease and remerges as a
global health emergency due to an alarming rise of antimicrobial resistance to its treatment …

Inhalation exposure to indoor air pollutants and cigarette smoke increases the risk of
developing tuberculosis (TB). Whether exposure to ambient air pollution particulate matter …

The huge amount of intestinal bacteria represents a continuing threat to the intestinal barrier.
To meet this challenge, gut epithelial cells produce antimicrobial peptides (AMP) that act at …

Human tuberculosis remains a huge global public health problem with an estimated 1/3rd of
the population being infected. Defensins are antibacterial cationic peptides produced by a …

Pulmonary tuberculosis (PTB) is a major public health problem in China. Minqin, a
Northwest county of China, has a very high number of annual PTB clinic visits and it is also …

Vitamin D plays a large role in the innate immune response against Mycobacterium
tuberculosis (MTB) infection, activation and progression. Likewise, vitamin D deficiency is …

Tuberculosis (TB), a leading infectious disease caused by the pathogen Mycobacterium
tuberculosis, poses a significant treatment challenge due to its unique characteristics and …

The increasing number of people with type 2 diabetes (DM2) is alarming and if it is taken
into account that the relative odds of developing tuberculosis in diabetic patients ranges …

Mycobacterium tuberculosis (Mtb) latent infection can lead to reactivation. The design of new
strategies to prevent it is an important subject. B6D2F1 mice were infected intratracheally …